Related Experiment Video
Updated: Jun 13, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans
H Oberkofler1, A Pfeifenberger, S Soyal
1Department of Laboratory Medicine, Landeskliniken and Paracelsus Private Medical University Salzburg, Müllner Hauptstr. 48, Salzburg, Austria. h.oberkofler@salk.at
Aims/Hypothesis:
The pseudokinase tribbles homologue 3 (Drosophila) (TRIB3) negatively interferes with insulin-mediated phosphorylation and activation of v-akt murine thymoma viral oncogene homologue 1 (AKT1, also known as protein kinase B). Animal studies have shown that Trib3 expression was higher in the fasting state and in animal models of diabetes, promoting hyperglycaemia presumably by increasing glucose production in the liver. Less is known about the role of TRIB3 in insulin resistance in humans, although a gain-of-function mutation associated with abnormalities related to insulin resistance has been described in TRIB3.
Methods:
We determined hepatic mRNA expression of TRIB3 and selected genes encoding enzymes, transcription factors and coactivators involved in glucose homeostasis. We also determined biochemical variables of intermediary metabolism in obese patients with varying degrees of insulin resistance.
Results:
In our study population hepatic TRIB3 mRNA expression was associated with surrogate markers of insulin resistance. TRIB3 expression was significantly increased in a subgroup with high HOMA of insulin resistance (HOMA-IR) compared with a low HOMA-IR group (p = 0.0033). TRIB3 transcript levels were correlated with PEPCK (also known as PCK2) mRNA expression (p = 0.0014) and mRNA expression of PPARGC1A (p = 0.0020), PPARGC1B (p < 0.0001), USF1 (p = 0.0017), FOXO1 (p = 0.0003) and SREBP-1c (also known as SREBF1; p = 0.0360). Furthermore ligands of peroxisome proliferator-activated receptor alpha/retinoid X receptor and overexpression of its coactivator PPARGC1A as well as overexpression of SREBP-1c and its coactivator PPARGC1B increased TRIB3 promoter activity in HepG2 cells.
Conclusions/Interpretation:
We have found evidence for a role of aberrant hepatic TRIB3 transcript levels in insulin resistance in obese humans and identified potential transcriptional pathways involved in regulation of TRIB3 gene expression in the liver.
Insights
Elevated hepatic TRIB3 (tribbles homologue 3) mRNA levels are linked to insulin resistance in obese humans. This study identifies potential gene regulation pathways for TRIB3 in the liver, offering insights into metabolic disease.
Area of Science:
- Molecular biology
- Human physiology
- Metabolic research
Background:
- Tribbles homologue 3 (Drosophila) (TRIB3) inhibits insulin signaling by interfering with v-akt murine thymoma viral oncogene homologue 1 (AKT1) phosphorylation.
- Animal studies indicate increased TRIB3 expression during fasting and in diabetes models, potentially exacerbating hyperglycemia via enhanced hepatic glucose production.
- Human data on TRIB3's role in insulin resistance is limited, though a gain-of-function mutation linked to insulin resistance has been reported.
Purpose of the Study:
- To investigate the association between hepatic TRIB3 mRNA expression and insulin resistance in obese humans.
- To identify potential transcriptional pathways regulating TRIB3 gene expression in the liver.
Main Methods:
- Quantification of hepatic TRIB3 mRNA and key glucose homeostasis gene expression in obese patients with varying insulin resistance.
- Assessment of biochemical variables related to intermediary metabolism.
- In vitro analysis of TRIB3 promoter activity in HepG2 cells using specific nuclear receptor ligands and coactivators.
Main Results:
- Hepatic TRIB3 mRNA expression correlated significantly with surrogate markers of insulin resistance in the study population.
- A subgroup with high HOMA of insulin resistance (HOMA-IR) exhibited significantly increased TRIB3 mRNA levels compared to a low HOMA-IR group.
- TRIB3 transcript levels showed positive correlations with mRNA expression of key metabolic regulators including PEPCK, PPARGC1A, PPARGC1B, USF1, FOXO1, and SREBP-1c.
- Peroxisome proliferator-activated receptor alpha/retinoid X receptor pathway activation and overexpression of PPARGC1A, SREBP-1c, and PPARGC1B enhanced TRIB3 promoter activity in HepG2 cells.
Conclusions:
- Aberrant hepatic TRIB3 transcript levels are implicated in insulin resistance among obese humans.
- Potential transcriptional pathways, including those involving PPARGC1A, PPARGC1B, and SREBP-1c, are identified as regulators of TRIB3 gene expression in the liver.
Related Concept Videos
Obesity
Insulin: The Receptor and Signaling Pathways
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Cell Specific Gene Expression
